Biodegradation, biodistribution and toxicity of chitosan

被引:1348
作者
Kean, T. [2 ]
Thanou, M. [1 ]
机构
[1] Kings Coll London, Div Pharmaceut Sci, London SE1 9NH, England
[2] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA
关键词
Chitosan; Biodegradation; Biodistribution; Toxicity; Delivery; In vitro; In vivo; ACIDIC MAMMALIAN CHITINASE; N-SUCCINYL-CHITOSAN; POORLY ABSORBABLE DRUGS; O-SULFATE CHITOSAN; TAY-SACHS-DISEASE; IN-VITRO; MOLECULAR-WEIGHT; PHOTOCROSSLINKABLE CHITOSAN; ABSORPTION ENHANCERS; ASPERGILLUS-NIGER;
D O I
10.1016/j.addr.2009.09.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chitosan is a natural polysaccharide that has attracted significant scientific interest during the last two decades. It is a potentially biologically compatible material that is chemically versatile (-NH2 groups and various M-w). These two basic properties have been used by drug delivery and tissue engineering scientists to create a plethora of formulations and scaffolds that show promise in healthcare. Despite the high number of published studies, chitosan is not approved by the FDA for any product in drug delivery, and as a consequence very few biotech companies are using this material. This review will aim to provide information on these biological properties that affect chitosan's safe use in drug delivery. The term "Chitosan" represents a large group of structurally different chemical entities that may show different biodistribution, biodegradation and toxicological profiles. Here we aim to review research in this area and critically discuss chitosan's potential to be used as a generally regarded as safe (GRAS) material. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:3 / 11
页数:9
相关论文
共 98 条
[1]   Production of recombinant β-hexosaminidase A, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methylotrophic yeast Ogataea minuta [J].
Akeboshi, Hiromi ;
Chiba, Yasunori ;
Kasahara, Yoshiko ;
Takashiba, Minako ;
Takaoka, Yuki ;
Ohsawa, Mai ;
Tajima, Youichi ;
Kawashima, Ikuo ;
Tsuji, Daisuke ;
Itoh, Kohji ;
Sakuraba, Hitoshi ;
Jigami, Yoshifumi .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2007, 73 (15) :4805-4812
[2]   Factors affecting the clearance and biodistribution of polymeric nanoparticles [J].
Alexis, Frank ;
Pridgen, Eric ;
Molnar, Linda K. ;
Farokhzad, Omid C. .
MOLECULAR PHARMACEUTICS, 2008, 5 (04) :505-515
[3]   Purification and characterization of a new hyperthermostable, allosamidin-insensitive and denaturation-resistant chitinase from the hyperthermophilic archaeon Thermococcus chitonophagus [J].
Andronopoulou, E ;
Vorgias, CE .
EXTREMOPHILES, 2003, 7 (01) :43-53
[4]  
[Anonymous], P ACS DIV POL MAT SC
[5]  
Arai K., 1968, B TOKAI REG FISH RES, V56, P89, DOI [10.3390/md12126236, DOI 10.3390/MD12126236]
[6]   Chitosan membrane as a wound-healing dressing: Characterization and clinical application [J].
Azad, AK ;
Sermsintham, N ;
Chandrkrachang, S ;
Stevens, WF .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2004, 69B (02) :216-222
[7]   Labeling efficiency and biodistribution of Technetium-99m labeled nanoparticles: interference by colloidal tin oxide particles [J].
Banerjee, T ;
Singh, AK ;
Sharma, RK ;
Maitra, AN .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 289 (1-2) :189-195
[8]   Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles [J].
Banerjee, T ;
Mitra, S ;
Singh, AK ;
Sharma, RK ;
Maitra, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 243 (1-2) :93-105
[9]   Alginate-chitosan complex coacervation for cell encapsulation: Effect on mechanical properties and on long-term viability [J].
Baruch, Limor ;
Machluf, Marcelle .
BIOPOLYMERS, 2006, 82 (06) :570-579
[10]   Identification of a novel acidic mammalian chitinase distinct from chitotriosidase [J].
Boot, RG ;
Blommaart, EFC ;
Swart, E ;
Ghauharali-van der Vlugt, K ;
Bijl, N ;
Moe, C ;
Place, A ;
Aerts, JMFG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (09) :6770-6778